Health care legislation business Frier Levitt has analyzed FDA enforcement actions versus “research only” peptide suppliers. Their conclusion: the FDA considers an item’s classification based on its intended use, not its disclaimers. When Web sites consist of dosage guides, reconstitution Guidance,